Antiproliferative effect of L-NAME on rat vascular smooth muscle cells

Life Sciences

Volumn 67, Issue 13, 2000, Pages 1613-1623

  El Mabrouk, Mohammed ^a   Singh, Ava ^a   Touyz, Rhian M ^a   Schiffrin, Ernesto L ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Cultured cells; Extracellular signal regulated kinases; Hyperplasia; Hypertrophy; L NAME; Nitric oxide synthase inhibitors; Vascular smooth muscle cells

Indexed keywords

AMINOGUANIDINE; DNA; MITOGEN ACTIVATED PROTEIN KINASE; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; PLATELET DERIVED GROWTH FACTOR BB;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG EFFECT; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GROWTH INHIBITION; IMMUNOBLOTTING; NONHUMAN; RAT; VASCULAR SMOOTH MUSCLE;

ANIMALS; ARGININE; CELL DIVISION; CULTURE MEDIA; DNA; DRUG INTERACTIONS; ENZYME INHIBITORS; GROWTH INHIBITORS; GUANIDINES; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; PHOSPHORYLATION; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, SPRAGUE-DAWLEY; THYMIDINE;

ANIMALIA; BOVINAE;

EID: 0034682954     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(00)00744-X     Document Type: Article

References (38)

1. Nitric oxide synthase: Role in the genesis of vascular disease
2. Balloon injury and interleukin-1 beta induce nitric oxide synthase activity in rat carotid arteries
3. Neuronal nitric oxide synthase is expressed in rat vascular smooth muscle cells: Activation by angiotensin II in hypertension
4. N-nitro-L-arginine and N-monomethyl-L-arginine exhibit a different pattern of inactivation toward the three nitric oxide synthases
5. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo
6. Inducible nitric oxide synthase in vascular smooth muscle cells from prehypertensive spontaneously hypertensive rats
7. Electron transfer in the nitric-oxide synthases. Characterization of L-arginine analogs that block heme iron reduction
8. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine
9. Selective inhibitors of neuronal nitric oxide synthase - Is no NOS really good NOS for the nervous system?
10. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells
11. Inhibition of rat mesangial cell mitogenesis by nitric oxide-generating vasodilators
12. Nitric oxide-induced downregulation of Cdk2 activity and cyclin A gene transcription in vascular smooth muscle cells
13. Induction of the cyclin-dependent kinase inhibitor p21 (Sdi1/Cip1/Waf1) by nitric oxide-generating vasodilator in vascular smooth muscle cells
14. The L-arginine-nitric oxide pathway
15. Cardiac weight in hypertension induced by nitric oxide synthase blockade
16. Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist
17. No evidence for vascular remodelling during hypertension induced by chronic inhibition of nitric oxide synthase in Brattleboro rats
18. Inhibition of nitric oxide in rats. Regulation of cardiovascular structure and expression of insulin-like growth factor I and its receptor messenger RNA
19. Vascular structure and expression of endothelin-1 gene in L-NAME-treated spontaneously hypertensive rats
20. Nitric oxide synthase inhibition by N(omega)-nitro-L-arginine methyl ester modulates G-protein expression and adenylyl cyclase activity in rat heart
21. Blunted cardiovascular growth induction during prolonged nitric oxide synthase blockade
22. Effect of hypertension induced by nitric oxide synthase inhibition on structure and function of resistance arteries in the rat
23. Effect of chronic inhibition of nitric oxide synthesis on vascular structure: Remodeling or growth?
24. Vascular structure in NG-nitro-L-arginine methyl ester-induced hypertension: Methodological considerations for studies of small arteries in hypertension
25. Nitric oxide: Physiology, pathophysiology, and pharmacology
26. Pharmacology of smooth muscle cell replication
27. Regulation of MAP kinase activity by growth stimuli in vascular smooth muscle
28. Efficacy of agonist-stimulated MEK activation determines the susceptibility of mitogen-activated protein (MAP) kinase to inhibition in rat aortic smooth muscle cells
29. Treatment of vascular smooth muscle cells with antisense phosphorothioate oligodeoxynucleotides directed against p42 and p44 mitogen-activated protein kinases abolishes DNA synthesis in response to platelet-derived growth factor
30. Receptors for atrial natriuretic factor in cultured vascular smooth muscle cells
31. Receptor-mediated effects of angiotensin II on growth of vascular smooth muscle cells from spontaneously hypertensive rats
32. NG-nitro L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists
33. Characterization of the muscarinic receptors in the mesenteric vascular bed of spontaneously hypertensive rats
34. Acetylcholine analogue stimulates DNA synthesis in brain-derived cells via specific muscarinic receptor subtypes
35. Growth factor-like effects mediated by muscarinic receptors in PC12M1 cells
36. The non specificity of specific nitric oxide synthase inhibitors
37. Impairment of osteoblast growth by nitric oxide synthase inhibitors: An effect independent of nitric oxide and arginine transport inhibition
38. Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): Requirement for bioactivation to the free acid, NG-nitro-L-arginine